Clinical Trial Update: Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 1/2 prime-boost immunotherapeutic trial for men with biochemical recurrence after definitive local…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Prime-boost immunotherapy (Barinthus Biotherapeutics)

Snippet

Sponsor: Barinthus Biotherapeutics | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-11-10